Table 6 Risk factors for potentially blinding leprosy related ocular pathology (PBLROP)*.
| Hazard ratio | SE | p Value | 95% CI | |
|---|---|---|---|---|
| Patient characteristics: | ||||
| Age (per 10 years) | 1.271 | 0.183 | 0.095 | 0.959 to 1.685 |
| Female v male | 0.395 | 0.245 | 0.135 | 0.117 to 1.334 |
| Leprosy characteristics: | ||||
| Classification (LL v BL) | 3.756 | 3.852 | 0.197 | 0.503 to 28.036 |
| Duration of disease | ||||
| Duration ⩾1 year v <1 year | 0.859 | 0.359 | 0.716 | 0.379 to 1.948 |
| Reaction | ||||
| Type I reaction at enrolment | 1.206 | 0.614 | 0.713 | 0.444 to 3.273 |
| Type II reaction at enrolment | 1.002 | 1.353 | 0.999 | 0.071 to 14.132 |
| History of any reactions | 1.272 | 0.704 | 0.664 | 0.430 to 3.761 |
| History of face patch v no face patch | 1.050 | 0.444 | 0.909 | 0.458 to 2.405 |
| Smear | ||||
| Bacterial index at enrolment | 0.712 | 0.138 | 0.079 | 0.488 to 1.040 |
| Smear positive v smear negative | 1.155 | 0.637 | 0.794 | 0.392 to 3.404 |
| Deformity | ||||
| Grade 2 deformity v no grade 2 deformity in all limbs | 4.739 | 3.519 | 0.036 | 1.106 to 20.313 |
*SE, standard error; 95% CI, 95% confidence interval; PBLROP includes lagophthalmos and/or uveal conditions; LL, lepromatous leprosy, BL, borderline lepromatous leprosy.